Basel-based Roche says it will pay $3.70 per share, a premium of more than 250 percent on Anadys's closing price Friday. Roche said in a statement Monday that the acquisition would boost its portfolio of drugs to treat hepatitis C. San Diego-based ... Roche Holding AG to buy US-based Anadys Pharmaceuticals for $230 million
Sunday, October 16, 2011
Roche Holding AG to buy US-based Anadys Pharmaceuticals for $230 million
Basel-based Roche says it will pay $3.70 per share, a premium of more than 250 percent on Anadys's closing price Friday. Roche said in a statement Monday that the acquisition would boost its portfolio of drugs to treat hepatitis C. San Diego-based ... Roche Holding AG to buy US-based Anadys Pharmaceuticals for $230 million
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment